Onderzoeker
Cédric Draulans
- Disciplines:Kankertherapie
Affiliaties
- Laboratorium Experimentele Radiotherapie (Afdeling)
Lid
Vanaf1 aug 2016 → Heden
Projecten
1 - 1 of 1
- De schatkamer der beelden: de rol van beeldvorming bij de diagnose en behandeling van prostaatkankerVanaf1 aug 2016 → 23 nov 2020Financiering: Privé-financiering van binnenlandse oorsprong - onbepaald
Publicaties
11 - 20 van 33
- A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy(2021)
Auteurs: Cédric Draulans, Eric Van Cutsem, Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel, Karin Haustermans
Pagina's: 1121 - 1125 - Ga-68-PSMA-11 PET, F-18-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability(2021)
Auteurs: Cédric Draulans, Raymond Oyen, Sofie Isebaert, Frederik Maes, Steven Joniau, Robin De Roover, Gilles Defraene, Karolien Goffin, Karin Haustermans
Pagina's: 202 - 211 - Optimal68Ga-PSMA and18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer(2021)
Auteurs: Cédric Draulans, Robin De Roover, Sofie Isebaert, Frederik Maes, Raymond Oyen, Steven Joniau, Karolien Goffin, Karin Haustermans
Pagina's: 1211 - 1218 - Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial(2021)
Auteurs: Karin Haustermans, Cédric Draulans, Sofie Isebaert
Pagina's: 787 - + - The Treasury of Images: exploring the opportunities for diagnosing and treating prostate cancer(2020)
Auteurs: Cédric Draulans, Karin Haustermans, Frederik Maes, Sofie Isebaert
- Knowledge-Based Assessment of Focal Dose Escalation Treatment Plans in Prostate Cancer(2020)
Auteurs: Cédric Draulans, Robin De Roover, Karin Haustermans
Pagina's: 1055 - 1062 - Five-Year Toxicity after EBRT for Localized Prostate Cancer with or without a Simultaneously Integrated Focal Boost up to 95Gy: Results of a Randomized Controlled Trial(2020)
Auteurs: L Kerkmeijer, V Groen, FJ Pos, E Monninkhof, RJ Smeenk, M Kunze-Busch, H de Boer, J Van der Voort vanZyp, M van Vulpen, Cédric Draulans, et al.
Pagina's: S61 - S62 - Radiotherapie bij primaire prostaatkanker: als minder meer wordt(2020)
Auteurs: Cédric Draulans, Charlien Berghen, Gert De Meerleer, Steven Joniau, Sofie Isebaert, Karin Haustermans
Pagina's: 1098 - 1106 - Ga-68-PSMA-11-PET, F-18-PSMA-1007-PET and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Inter-tracer Variability(2020)
Auteurs: Cédric Draulans, FJ Pos, RJ Smeenk, L Kerkmeijer, W Vogel, J Nagarajah, M Janssen, C Mai, S Heijmink, M van der Leest, et al.
Pagina's: E878 - E878 - Optimal Ga-68-PSMA-11 and F-18-PSMA-1007 PET window levelling for gross tumour volume delineation in primary prostate cancer(2020)
Auteurs: K Goffin, Cédric Draulans, R De Roover, UA van der Heide, L Kerkmeijer, RJ Smeenk, F Pos, WV Vogel, J Nagarajah, M Janssen, et al.
Pagina's: S404 - S405